Evidence map›Paper›PMID 39860468›Full record

ReviewJournal of clinical medicine2025

Strategies for Early Keratoconus Diagnosis: A Narrative Review of Evaluating Affordable and Effective Detection Techniques.

Arige Gideon Abou Said, Joan Gispets, Einat Shneor

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. The relationship between correction modality and clinical signs and symptoms of dry eye and meibomian gland dysfunction in keratoconic patients.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arige Gideon Abou SaidDepartment of Optometry and Vision Science, Hadassah Academic College, Jerusalem 9101001, Israel.
Joan GispetsDepartment of Optics and Optometry, Universitat Politècnica de Catalunya, Violinista Vellsolà, 37, 08222 Terrassa, Spain.
Einat ShneorDepartment of Optometry and Vision Science, Hadassah Academic College, Jerusalem 9101001, Israel.ORCID 0000-0002-7842-5071

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratoconus is a progressive corneal disorder that can lead to irreversible visual impairment if not detected early. Despite its high prevalence, early diagnosis is often delayed, especially in low-to-middle-income countries due to limited awareness and restricted access to advanced diagnostic tools such as corneal topography, tomography, optical coherence tomography, and corneal biomechanical assessments. These technologies are essential for identifying early-stage keratoconus, yet their high cost limits accessibility in resource-limited settings. While cost and portability are important for accessibility, the sensitivity and specificity of diagnostic tools must be considered as primary metrics to ensure accurate and effective detection of early keratoconus. This review examines both traditional and advanced diagnostic techniques, including the use of machine learning and artificial intelligence, to enhance early diagnosis. Artificial intelligence-based approaches show significant potential for transforming keratoconus diagnosis by improving the accuracy and sensitivity of early diagnosis, especially when combined with imaging devices. Notable innovations include tools such as SmartKC, a smartphone-based machine-learning application, mobile corneal topography through the null-screen test, and the Smartphone-based Keratograph, providing affordable and portable solutions. Additionally, contrast sensitivity testing demonstrates potential for keratoconus detection, although a precise platform for routine clinical use has yet to be established. The review emphasizes the need for increased awareness among clinicians, particularly in underserved regions, and advocates for the development of accessible, low-cost diagnostic tools. Further research is needed to validate the effectiveness of these emerging technologies in detecting early keratoconus.

Indexed as

diagnosisearly keratoconuskeratoconus

Identifiers

PMID39860468
PMCPMC11765535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.